Cargando…
Goals, Expectations, and the Definition of Success for Neuromodulation for Pain According to Representatives of Neuromodulation Device Manufacturers
Representatives of neuromodulation device manufacturers are expected to facilitate the relationship between patients and healthcare providers. Nevertheless, the goals, expectations, and definition of success for neuromodulation for pain have not yet been explored. Representatives present at the 2nd...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500654/ https://www.ncbi.nlm.nih.gov/pubmed/36143243 http://dx.doi.org/10.3390/jpm12091457 |
_version_ | 1784795273597288448 |
---|---|
author | Moens, Maarten Alliet, William Billot, Maxime De Smedt, Ann Flamée, Panagiotis Vanhonacker, Domien Roulaud, Manuel Rigoard, Philippe Goudman, Lisa |
author_facet | Moens, Maarten Alliet, William Billot, Maxime De Smedt, Ann Flamée, Panagiotis Vanhonacker, Domien Roulaud, Manuel Rigoard, Philippe Goudman, Lisa |
author_sort | Moens, Maarten |
collection | PubMed |
description | Representatives of neuromodulation device manufacturers are expected to facilitate the relationship between patients and healthcare providers. Nevertheless, the goals, expectations, and definition of success for neuromodulation for pain have not yet been explored. Representatives present at the 2nd Joint Congress of the INS European Chapters in September 2021 completed a survey to ascertain their opinions about the goals to achieve with neuromodulation, the factors that they expect to change, and their definition of success for neuromodulation. In total, 39 representatives completed the survey. To provide excellent service for patients (22.4%), to become a trusted partner for physicians (21.5%), and to provide excellent service for physicians (20.7%) were the highest ranked goals. The most frequently reported factors that were expected to change were pain intensity (23.1%), patient satisfaction (19.7%), mobility/functioning (14.5%), and capacity to return to work (13.7%). Within the definitions of success, increased quality of life of the patient was stated in 21% of the definitions, closely followed by pain control (19.3%) and happiness/patient satisfaction (15.8%). The goals of representatives of neuromodulation device manufacturers seem to focus on ensuring a good relationship with physicians on the one hand and providing good service towards patients on the other hand, whereby pain control, quality of life, and patient satisfaction seem to be important for company representatives. |
format | Online Article Text |
id | pubmed-9500654 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-95006542022-09-24 Goals, Expectations, and the Definition of Success for Neuromodulation for Pain According to Representatives of Neuromodulation Device Manufacturers Moens, Maarten Alliet, William Billot, Maxime De Smedt, Ann Flamée, Panagiotis Vanhonacker, Domien Roulaud, Manuel Rigoard, Philippe Goudman, Lisa J Pers Med Article Representatives of neuromodulation device manufacturers are expected to facilitate the relationship between patients and healthcare providers. Nevertheless, the goals, expectations, and definition of success for neuromodulation for pain have not yet been explored. Representatives present at the 2nd Joint Congress of the INS European Chapters in September 2021 completed a survey to ascertain their opinions about the goals to achieve with neuromodulation, the factors that they expect to change, and their definition of success for neuromodulation. In total, 39 representatives completed the survey. To provide excellent service for patients (22.4%), to become a trusted partner for physicians (21.5%), and to provide excellent service for physicians (20.7%) were the highest ranked goals. The most frequently reported factors that were expected to change were pain intensity (23.1%), patient satisfaction (19.7%), mobility/functioning (14.5%), and capacity to return to work (13.7%). Within the definitions of success, increased quality of life of the patient was stated in 21% of the definitions, closely followed by pain control (19.3%) and happiness/patient satisfaction (15.8%). The goals of representatives of neuromodulation device manufacturers seem to focus on ensuring a good relationship with physicians on the one hand and providing good service towards patients on the other hand, whereby pain control, quality of life, and patient satisfaction seem to be important for company representatives. MDPI 2022-09-06 /pmc/articles/PMC9500654/ /pubmed/36143243 http://dx.doi.org/10.3390/jpm12091457 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Moens, Maarten Alliet, William Billot, Maxime De Smedt, Ann Flamée, Panagiotis Vanhonacker, Domien Roulaud, Manuel Rigoard, Philippe Goudman, Lisa Goals, Expectations, and the Definition of Success for Neuromodulation for Pain According to Representatives of Neuromodulation Device Manufacturers |
title | Goals, Expectations, and the Definition of Success for Neuromodulation for Pain According to Representatives of Neuromodulation Device Manufacturers |
title_full | Goals, Expectations, and the Definition of Success for Neuromodulation for Pain According to Representatives of Neuromodulation Device Manufacturers |
title_fullStr | Goals, Expectations, and the Definition of Success for Neuromodulation for Pain According to Representatives of Neuromodulation Device Manufacturers |
title_full_unstemmed | Goals, Expectations, and the Definition of Success for Neuromodulation for Pain According to Representatives of Neuromodulation Device Manufacturers |
title_short | Goals, Expectations, and the Definition of Success for Neuromodulation for Pain According to Representatives of Neuromodulation Device Manufacturers |
title_sort | goals, expectations, and the definition of success for neuromodulation for pain according to representatives of neuromodulation device manufacturers |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500654/ https://www.ncbi.nlm.nih.gov/pubmed/36143243 http://dx.doi.org/10.3390/jpm12091457 |
work_keys_str_mv | AT moensmaarten goalsexpectationsandthedefinitionofsuccessforneuromodulationforpainaccordingtorepresentativesofneuromodulationdevicemanufacturers AT allietwilliam goalsexpectationsandthedefinitionofsuccessforneuromodulationforpainaccordingtorepresentativesofneuromodulationdevicemanufacturers AT billotmaxime goalsexpectationsandthedefinitionofsuccessforneuromodulationforpainaccordingtorepresentativesofneuromodulationdevicemanufacturers AT desmedtann goalsexpectationsandthedefinitionofsuccessforneuromodulationforpainaccordingtorepresentativesofneuromodulationdevicemanufacturers AT flameepanagiotis goalsexpectationsandthedefinitionofsuccessforneuromodulationforpainaccordingtorepresentativesofneuromodulationdevicemanufacturers AT vanhonackerdomien goalsexpectationsandthedefinitionofsuccessforneuromodulationforpainaccordingtorepresentativesofneuromodulationdevicemanufacturers AT roulaudmanuel goalsexpectationsandthedefinitionofsuccessforneuromodulationforpainaccordingtorepresentativesofneuromodulationdevicemanufacturers AT rigoardphilippe goalsexpectationsandthedefinitionofsuccessforneuromodulationforpainaccordingtorepresentativesofneuromodulationdevicemanufacturers AT goudmanlisa goalsexpectationsandthedefinitionofsuccessforneuromodulationforpainaccordingtorepresentativesofneuromodulationdevicemanufacturers |